With 4.63 million shares changed hands, the volume of the stock remained heavier than its average volume of 4.0 million shares. During the session, the Chemicals company that operates in wider Basic Materials sector, reached to the highest price of $10.56 whereas the lowest price it dropped to was $10.135. The 52-week range on HUN shows that it touched its highest point at $25.12 and its lowest point at $10.24 during that stretch. It currently has a 1-year price target of $14.73. With its current market cap of 1.83 billion, HUN has annualized dividend of $1.00 while the current yield stands at 9.51%. HUN paid its most recent dividend on 1749772800, while the ex-dividend date for that was 1749772800. Beta for the stock currently stands at 0.75.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HUN was down-trending over the past week, with a drop of -3.58%, but this was down by -10.32% over a month. Three-month performance dropped to -35.40% while six-month performance fell -43.37%. The stock lost -41.71% in the past year, while it has lost -54.24% so far this year. A look at the trailing 12-month EPS for HUN yields -0.75 with Next year EPS estimates of 0.25. For the next quarter, that number is -0.12. This implies an EPS growth rate of -350.71% for this year and 170.70% for next year.
Float and Shares Shorts:
At present, 172.60 million HUN shares are outstanding with a float of 163.69 million shares on hand for trading. On 2025-05-30, short shares totaled 8.53 million, which was 490.99997 higher than short shares on 1745971200. In addition to Mr. Peter R. Huntsman as the firm’s Chairman, President & CEO, Mr. Philip M. Lister ACMA serves as its Executive VP & CFO.
Institutional Ownership:
Through their ownership of 0.88969004 of HUN’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-03-31, HUN reported revenue of $1410000000.0 and operating income of $10000000.0. The EBITDA in the recently reported quarter was $83000000.0 and diluted EPS was -$0.03.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HUN since 10 analysts follow the stock currently. There are 7 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With HUN analysts setting a high price target of 20.0 and a low target of 12.0, the average target price over the next 12 months is 13.76923. Based on these targets, HUN could surge 90.29% to reach the target high and rise by 14.18% to reach the target low. Reaching the average price target will result in a growth of 31.01% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.08133258 being high and $0.0728051 being low. For HUN, this leads to a yearly average estimate of $0.076959.
